GRT6019

DRUG2 trials

Sponsors

Grünenthal GmbH

Conditions

Duchenne Muscular Dystrophy (DMD)

Phase 1

A Trial to Investigate Safety and Pharmacokinetics of GRT6019, Including Food Effect, in Healthy Male Participants

CompletedNCT07317063

Grünenthal GmbHDuchenne Muscular Dystrophy (DMD)

Start: 2025-11-21End: 2026-01-06Updated: 2026-02-13

A Trial to Investigate the Safety and Pharmacokinetics of GRT6019 in Healthy Male Participants

CompletedNCT07347548

Grünenthal GmbHDuchenne Muscular Dystrophy (DMD)

Start: 2026-01-06End: 2026-06-09Updated: 2026-08-12